You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雅各臣科研製藥(02633.HK)獲控股股東及董事會主席岑廣業增持合共2053.2萬股
格隆匯 03-14 18:09

格隆匯3月14日丨雅各臣科研製藥(02633.HK)發佈公吿,公司董事會獲岑廣業先生(公司控股股東、執行董事、董事會主席兼行政總裁)吿知,於2021年12月15日至2022年3月14日期間,彼透過其控制實體在市場上以總代價約1346萬港元(相當於平均價格每股約0.6555港元)增持合共2053.2萬股公司股份,佔公司於本公吿日期已發行股本總額約1.06%。

緊隨增持事項後,岑先生於合共11.6億股股份中擁有權益,佔公司於本公吿日期已發行股本總額約60.01%。

據岑先生表示,彼對集團的未來前景及長遠發展充滿信心,並可能考慮在適用法律及法規的規限下進一步增持公司的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account